| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1365-4362.1993.TB02790.X |
| P698 | PubMed publication ID | 8444530 |
| P2093 | author name string | N J Schork | |
| C N Ellis | |||
| A K Gupta | |||
| M A Gupta | |||
| S Kirkby | |||
| P433 | issue | 3 | |
| P921 | main subject | suicidal ideation | Q944142 |
| P304 | page(s) | 188-190 | |
| P577 | publication date | 1993-03-01 | |
| P1433 | published in | International Journal of Dermatology | Q15752742 |
| P1476 | title | Suicidal ideation in psoriasis | |
| P478 | volume | 32 |
| Q36364466 | A Cross-sectional Study of Prevalence and Implications of Depression and Anxiety in Psoriasis |
| Q27334725 | A multicenter, non-interventional study to evaluate patient-reported experiences of living with psoriasis |
| Q64883748 | Asian consensus on assessment and management of mild to moderate plaque psoriasis with topical therapy. |
| Q47621905 | Assessing illness-related stress in psoriasis: the psychometric properties of the Psoriasis Life Stress Inventory |
| Q43881110 | Attentional bias for psoriasis-specific and psychosocial threat in patients with psoriasis |
| Q24235424 | Biologics for chronic plaque psoriasis |
| Q24242281 | Biologics for chronic plaque psoriasis |
| Q34351604 | Budget impact analysis of ustekinumab in the management of moderate to severe psoriasis in Greece |
| Q34253312 | Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U.K. |
| Q36083240 | Disease Severity, Quality of Life, and Psychiatric Morbidity in Patients With Psoriasis With Reference to Sociodemographic, Lifestyle, and Clinical Variables: A Prospective, Cross-Sectional Study From Lahore, Pakistan. |
| Q37857668 | Emerging treatments in the management of psoriasis: biological targeting with ustekinumab |
| Q36393754 | Emotional benefit of cosmetic camouflage in the treatment of facial skin conditions: personal experience and review |
| Q92236572 | Evaluating guselkumab: an anti-IL-23 antibody for the treatment of plaque psoriasis |
| Q48011146 | General measures and quality of life issues in psoriasis |
| Q37406946 | Genome-wide association scan yields new insights into the immunopathogenesis of psoriasis |
| Q37441334 | Global gene expression analysis reveals evidence for decreased lipid biosynthesis and increased innate immunity in uninvolved psoriatic skin |
| Q25256974 | Impact of efalizumab on patient-reported outcomes in high-need psoriasis patients: results of the international, randomized, placebo-controlled Phase III Clinical Experience Acquired with Raptiva (CLEAR) trial [NCT00256139]. |
| Q33903607 | Introduction. The magnitude of skin disease in the United States |
| Q74256817 | Is the efficacy of topical corticosteroid therapy for psoriasis vulgaris enhanced by concurrent moclobemide therapy? A double-blind, placebo-controlled study |
| Q46701286 | Long-term control of psoriasis is necessary |
| Q37930978 | Management of psoriatic arthritis from the view of the dermatologist |
| Q37610764 | Molecular dissection of psoriasis: integrating genetics and biology |
| Q47722106 | Pain, Psychological Comorbidities, Disability, and Impaired Qualify of Life in Hidradenitis Suppurativa |
| Q51080846 | Patients' illness perceptions and coping as predictors of functional status in psoriasis: a 1-year follow-up. |
| Q38443811 | Psoriasis and psycho-dermatology |
| Q41686702 | Psoriasis causes as much disability as other major medical diseases |
| Q28088340 | Psoriasis: classical and emerging comorbidities |
| Q24675003 | Psoriasis: epidemiology, clinical features, and quality of life |
| Q24678956 | Psychodermatology: a guide to understanding common psychocutaneous disorders |
| Q40997099 | Psychodermatology: an update |
| Q36376926 | Psychological Morbidity Among Dermatological Patients in a Rural Setting |
| Q91671860 | Psychological Stress and Depression in Psoriasis Patients - a Dermatologist's Perspective |
| Q40969676 | Psychological and psychophysiological aspects of psoriasis. |
| Q34131556 | Psychosocial effect of common skin diseases |
| Q21245617 | Quality of life in patients with psoriasis |
| Q34156304 | Relevance of psychiatry in dermatology: Present concepts |
| Q58694680 | Secukinumab in the treatment of psoriasis: patient selection and perspectives |
| Q34658035 | Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene |
| Q41943637 | Suicide risk and psychiatric comorbidity in patients with psoriasis. |
| Q37303223 | Targeted treatment of psoriasis with adalimumab: a critical appraisal based on a systematic review of the literature |
| Q54956609 | The Pathophysiological Mechanisms and the Quest for Biomarkers in Psoriasis, a Stress-Related Skin Disease. |
| Q39218034 | The Role of Pharmacogenetics in Chronic Plaque Psoriasis: Update of the Literature. |
| Q38044995 | The burden of moderate to severe psoriasis: an overview |
| Q37172521 | The health-related quality of life in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a comparison with a selected sample of healthy people |
| Q58698647 | The impact of genital psoriasis on quality of life: a systematic review |
| Q26862537 | The prevalence and odds of depressive symptoms and clinical depression in psoriasis patients: a systematic review and meta-analysis |
| Q35228919 | The psychological burden of skin diseases: a cross-sectional multicenter study among dermatological out-patients in 13 European countries |
| Q34083409 | The risk of depression, anxiety, and suicidality in patients with psoriasis: a population-based cohort study |
| Q37081486 | Update on the natural history and systemic treatment of psoriasis |
| Q49210038 | Updates on Psoriasis and Cutaneous Oncology: Proceedings from the 2017 MauiDerm Meeting |
| Q84279858 | [Comorbidities in psoriasis] |
Search more.